Suppr超能文献

巨人症和肢端肥大症的遗传学

Genetics of gigantism and acromegaly.

作者信息

Hannah-Shmouni Fady, Trivellin Giampaolo, Stratakis Constantine A

机构信息

Section on Endocrinology & Genetics (SEGEN), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH), Bethesda, MD 20892, USA.

Section on Endocrinology & Genetics (SEGEN), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH), Bethesda, MD 20892, USA.

出版信息

Growth Horm IGF Res. 2016 Oct-Dec;30-31:37-41. doi: 10.1016/j.ghir.2016.08.002. Epub 2016 Aug 10.

Abstract

Gigantism and acromegaly are rare disorders that are caused by excessive GH secretion and/or high levels of its mediator, IGF-1. Gigantism occurs when excess GH or IGF-1 lead to increased linear growth, before the end of puberty and epiphyseal closure. The majority of cases arise from a benign GH-secreting pituitary adenoma, with an incidence of pituitary gigantism and acromegaly of approximately 8 and 11 per million person-years, respectively. Over the past two decades, our increasing understanding of the molecular and genetic etiologies of pituitary gigantism and acromegaly yielded several genetic causes, including multiple endocrine neoplasia type 1 and 4, McCune-Albright syndrome, Carney complex, familial isolated pituitary adenoma, pituitary adenoma association due to defects in familial succinate dehydrogenase genes, and the recently identified X-linked acrogigantism. The early diagnosis of these conditions helps guide early intervention, screening, and genetic counseling of patients and their family members. In this review, we provide a concise and up-to-date discussion on the genetics of gigantism and acromegaly.

摘要

巨人症和肢端肥大症是罕见的疾病,由生长激素(GH)分泌过多和/或其介质胰岛素样生长因子-1(IGF-1)水平升高引起。当青春期结束和骨骺闭合之前,过量的GH或IGF-1导致线性生长增加时,就会发生巨人症。大多数病例源于良性分泌GH的垂体腺瘤,垂体巨人症和肢端肥大症的发病率分别约为每百万人年8例和11例。在过去二十年中,我们对垂体巨人症和肢端肥大症的分子和遗传病因的认识不断增加,发现了多种遗传病因,包括1型和4型多发性内分泌腺瘤病、McCune-Albright综合征、Carney综合征、家族性孤立性垂体腺瘤、由于家族性琥珀酸脱氢酶基因缺陷导致的垂体腺瘤关联,以及最近发现的X连锁肢端肥大症。这些疾病的早期诊断有助于指导患者及其家庭成员的早期干预、筛查和遗传咨询。在本综述中,我们对巨人症和肢端肥大症的遗传学进行了简明且最新的讨论。

相似文献

1
Genetics of gigantism and acromegaly.巨人症和肢端肥大症的遗传学
Growth Horm IGF Res. 2016 Oct-Dec;30-31:37-41. doi: 10.1016/j.ghir.2016.08.002. Epub 2016 Aug 10.
2
Screening for genetic causes of growth hormone hypersecretion.筛查生长激素分泌过多的遗传原因。
Growth Horm IGF Res. 2016 Oct-Dec;30-31:52-57. doi: 10.1016/j.ghir.2016.10.004. Epub 2016 Oct 12.
4
Familial gigantism.家族性巨人症。
Clinics (Sao Paulo). 2012;67 Suppl 1(Suppl 1):29-32. doi: 10.6061/clinics/2012(sup01)06.
6
Gigantism: X-linked acrogigantism and GPR101 mutations.巨人症:X连锁肢端巨大症与GPR101突变
Growth Horm IGF Res. 2016 Oct-Dec;30-31:64-69. doi: 10.1016/j.ghir.2016.09.007. Epub 2016 Sep 29.
7
Pituitary gigantism: Causes and clinical characteristics.垂体巨人症:病因及临床特征。
Ann Endocrinol (Paris). 2015 Dec;76(6):643-9. doi: 10.1016/j.ando.2015.10.002. Epub 2015 Nov 14.
10
Genetics of Acromegaly and Gigantism.肢端肥大症和巨人症的遗传学
J Clin Med. 2021 Mar 29;10(7):1377. doi: 10.3390/jcm10071377.

引用本文的文献

6
Delving into Acromegaly.深入探究肢端肥大症。
J Clin Med. 2023 Feb 19;12(4):1654. doi: 10.3390/jcm12041654.
7
Development and evaluation of the Acromegaly Symptom Diary.肢端肥大症症状日记的制定与评估。
J Patient Rep Outcomes. 2023 Feb 15;7(1):15. doi: 10.1186/s41687-023-00541-7.
9
Genetic and Epigenetic Pathogenesis of Acromegaly.肢端肥大症的遗传和表观遗传发病机制
Cancers (Basel). 2022 Aug 10;14(16):3861. doi: 10.3390/cancers14163861.

本文引用的文献

6
GHRH excess and blockade in X-LAG syndrome.X连锁肢端肥大症综合征中的生长激素释放激素过量与阻断
Endocr Relat Cancer. 2016 Mar;23(3):161-70. doi: 10.1530/ERC-15-0478. Epub 2015 Dec 15.
9
Carney complex: an update.卡尼综合征:最新进展
Eur J Endocrinol. 2015 Oct;173(4):M85-97. doi: 10.1530/EJE-15-0209. Epub 2015 Jun 30.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验